Compare PKOH & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PKOH | OVID |
|---|---|---|
| Founded | 1907 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 553.5M | 522.6M |
| IPO Year | 1994 | 2017 |
| Metric | PKOH | OVID |
|---|---|---|
| Price | $38.47 | $2.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $37.00 | $4.60 |
| AVG Volume (30 Days) | 81.1K | ★ 2.7M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | N/A | ★ 3.90 |
| EPS | ★ 0.57 | N/A |
| Revenue | ★ $1,599,100,000.00 | $7,252,000.00 |
| Revenue This Year | $7.87 | N/A |
| Revenue Next Year | $3.42 | $19.34 |
| P/E Ratio | $66.96 | ★ N/A |
| Revenue Growth | N/A | ★ 1181.27 |
| 52 Week Low | $15.52 | $0.48 |
| 52 Week High | $39.69 | $3.11 |
| Indicator | PKOH | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 61.16 | 42.08 |
| Support Level | $33.76 | $2.23 |
| Resistance Level | $39.33 | $2.38 |
| Average True Range (ATR) | 1.66 | 0.16 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 81.52 | 6.60 |
Park-Ohio Holdings Corp is a diversified international company offering its clients supply chain management outsourcing services, capital equipment used on their production lines, and manufactured components used to assemble their products. The company operates through three reportable segments: Supply Technologies, Assembly Components, and Engineered Products. Maximum revenue is generated from the Supply Technologies segment, which is mainly engaged in sourcing, planning, and procurement of several production components, including fasteners, pins, nuts, bolts, valves, hoses, wire harnesses, clamps and fittings, etc. Geographically, the company generates maximum revenue from its business in the United States, followed by Europe, Asia, Mexico, Canada, and other regions.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.